Kraj: Australia
Język: angielski
Źródło: Department of Health (Therapeutic Goods Administration)
Influenza virus haemagglutinin, Quantity: 15 microgram
Viatris Pty Ltd
Suspension
Excipient Ingredients: magnesium chloride hexahydrate; monobasic potassium phosphate; dibasic sodium phosphate dihydrate; water for injections; potassium chloride; calcium chloride dihydrate; sodium chloride
Intramuscular, Subcutaneous
Tens pack (10 x syringes), Singles pack (1 x syringe)
(S4) Prescription Only Medicine
For the prevention of influenza caused by influenza virus, types A and B.,For full details regarding recommendations for influenza vaccination, please refer to the relevant National Immunisation Guidelines.,INFLUVAC TETRA is indicated in adults and children from 6 months of age and older.
Visual Identification: Colourless clear liquid, filled in single-dose syringes (glass, type I); Container Type: Syringe; Container Material: Glass Type I Clear; Container Life Time: 12 Months; Container Temperature: Store at 2 to 8 degrees Celsius
Licence status A
2017-11-02
INFLUVAC TETRA _Inactivated Quadrivalent Influenza Vaccine (surface antigen)_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some of the common questions about INFLUVAC TETRA vaccine. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. Please read it carefully and keep it for future reference. All medicines and vaccines have risks and benefits. Your doctor has weighed the possible risks of you having INFLUVAC TETRA against the expected benefits. TALK TO YOUR DOCTOR, NURSE OR PHARMACIST IF YOU HAVE ANY CONCERNS ABOUT RECEIVING INFLUVAC TETRA. Your doctor and pharmacist have more information. WHAT INFLUVAC TETRA IS USED FOR INFLUVAC TETRA is used to prevent certain types of influenza (commonly called flu). The vaccine works by causing the body to produce its own protection (antibodies) against four different types of influenza virus. Each year new types of influenza virus can appear, so every year INFLUVAC TETRA is changed to contain fragments of the new types of virus. Therefore, influenza vaccination is recommended every year. PLEASE NOTE THAT INFLUVAC TETRA WILL ONLY PROTECT YOU AGAINST THE FOUR TYPES OF INFLUENZA VIRUS USED TO MAKE THE VACCINE. IT WILL NOT PROTECT YOU FROM INFLUENZA CAUSED BY OTHER TYPES OF INFLUENZA VIRUS OR FROM INFECTIONS WITH OTHER AGENTS CAUSING FLU-LIKE SYMPTOMS (SUCH AS THE COMMON COLD). Influenza is an infectious illness. Influenza is spread by small droplets from the nose, throat or mouth of an infected person. Symptoms of influenza begin 48 hours after coming into contact with the virus. These consist of chills, fever, generalised aches and pains, headache and respiratory symptoms (sore throat, runny nose, cough). The severity and type of symptoms can vary. Most people recover completely within a week. The risk of serious complications (e.g. pneumonia and death) is greater in very young, very old and chronically ill persons. INFLUVAC TETRA can be used in adults over the age of 18 years. TALK Przeczytaj cały dokument
AUSTRALIAN PRODUCT INFORMATION INFLUVAC ® TETRA _(Influenza virus haemagglutinin) Suspension for Injection _ 1 NAME OF THE MEDICINE Quadrivalent Influenza Vaccine, surface antigen, inactivated (influenza virus haemagglutinin) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION INFLUVAC TETRA is a purified, inactivated influenza vaccine (surface antigen), containing the following four influenza strains recommended for the 2021 influenza season: • A/Victoria/2570/2019 (H1N1)pdm09-like strain (A/Victoria/2570/2019, IVR-215) • A/Hong Kong/2671/2019 (H3N2)-like strain (A/Hong Kong/2671/2019, IVR-208) • B/Washington/02/2019-like strain (B/Victoria lineage) (B/Washington/02/2019, wild type) • B/Phuket/3073/2013-like strain (B/Yamagata lineage) (B/Phuket/3073/2013, wild type) Each 0.5 mL dose contains 15 micrograms haemagglutinin per each of the above mentioned viral strains, for a combined total amount of 60 micrograms. Each strain has been propagated in fertilised hens’ eggs from healthy chickens. The type and amount of viral antigens in INFLUVAC TETRA conform to the requirements of the Australian Influenza Vaccine Committee (AIVC) and the New Zealand Ministry of Health for the 2021 southern hemisphere influenza season. For the full list of excipients, see Section 6.1 LIST OF EXCIPIENTS . 3 PHARMACEUTICAL FORM INFLUVAC TETRA is a clear colourless liquid for injection in pre-filled syringes (glass, type I). 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the prevention of influenza caused by influenza virus, types A and B. For full details regarding recommendations for influenza vaccination, please refer to the relevant National Immunisation Guidelines. INFLUVAC TETRA is indicated in adults and children from 6 months of age and older. 4.2 DOSE AND METHOD OF ADMINISTRATION ADULTS AND CHILDREN 6 MONTHS OF AGE AND OLDER : 0.5 mL dose For children less than 9 years of age who have not previously been vaccinated, a second dose of 0.5 mL should be given after an interval of at least 4 weeks. INFLUVAC ® TETRA – PRO Przeczytaj cały dokument